ArticleBMJ open2025

Efficacy and safety of novel complement inhibitors in atypical haemolytic uremic syndrome: a protocol for systematic review and meta-analysis.

Maulana Empitu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.